Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Partial remission, residual symptoms, and relapse in depression.

Paykel ES.

Dialogues Clin Neurosci. 2008;10(4):431-7. Review.

2.
3.

[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].

Mouchabac S, Ferreri M, Cabanac F, Bitton M.

Encephale. 2003 Sep-Oct;29(5):438-44. French.

PMID:
14615693
4.

Continuation and maintenance therapy in depression.

Paykel ES.

Br Med Bull. 2001;57:145-59.

PMID:
11719914
5.

Residual symptoms in depression: an emerging therapeutic target.

Fava GA, Fabbri S, Sonino N.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1019-27. Review.

PMID:
12452521
6.

Prevention of relapse in residual depression by cognitive therapy: a controlled trial.

Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M.

Arch Gen Psychiatry. 1999 Sep;56(9):829-35.

PMID:
12884889
7.

Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.

Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R.

Am J Psychiatry. 2003 Jul;160(7):1252-62.

PMID:
12832239
8.

The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.

Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, Mintz J.

J Clin Psychiatry. 2001 Aug;62(8):612-6.

PMID:
11561933
9.

Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.

Trivedi MH, Hollander E, Nutt D, Blier P.

J Clin Psychiatry. 2008 Feb;69(2):246-58. Review.

PMID:
18363453
10.

Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.

Goldberg JF, Harrow M.

J Affect Disord. 2005 Dec;89(1-3):79-89. Epub 2005 Oct 24.

PMID:
16249035
11.

Pharmacotherapy of depression and mixed states in bipolar disorder.

Montgomery SA, Schatzberg AF, Guelfi JD, Kasper S, Nemeroff C, Swann A, Zajecka J.

J Affect Disord. 2000 Sep;59 Suppl 1:S39-S56. Review.

PMID:
11121826
12.

Residual symptoms in depression: can treatment be symptom-specific?

Menza M, Marin H, Opper RS.

J Clin Psychiatry. 2003 May;64(5):516-23. Review.

PMID:
12755653
13.

Advances in the pharmacologic treatment of bipolar depression.

Keck PE Jr, Nelson EB, McElroy SL.

Biol Psychiatry. 2003 Apr 15;53(8):671-9. Review.

PMID:
12706953
14.

Achieving gains beyond response.

Paykel ES.

Acta Psychiatr Scand Suppl. 2002;(415):12-7. Review.

PMID:
12492768
15.

Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk.

O'Donovan C, Garnham JS, Hajek T, Alda M.

J Affect Disord. 2008 Apr;107(1-3):293-8. Epub 2007 Sep 12.

PMID:
17850879
16.

Prevalence and clinical correlates of residual depressive symptoms in bipolar II disorder.

Benazzi F.

Psychother Psychosom. 2001 Sep-Oct;70(5):232-8.

PMID:
11509892
17.

Clinical differences between early and late remission in depressive patients.

Roca M, García-Toro M, García-Campayo J, Vives M, Armengol S, García-García M, Asensio D, Gili M.

J Affect Disord. 2011 Nov;134(1-3):235-41. doi: 10.1016/j.jad.2011.05.051. Epub 2011 Jun 14.

PMID:
21676465
18.

Residual symptoms after partial remission: an important outcome in depression.

Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A.

Psychol Med. 1995 Nov;25(6):1171-80.

PMID:
8637947
19.

Bipolar depression: treatment options.

Yatham LN, Kusumakar V, Parikh SV, Haslam DR, Matte R, Sharma V, Kennedy S.

Can J Psychiatry. 1997 Aug;42 Suppl 2:87S-91S. Review.

PMID:
9288441
20.

Treatment of major depression: is improvement enough?

Ferrier IN.

J Clin Psychiatry. 1999;60 Suppl 6:10-4. Review.

Supplemental Content

Support Center